Skip to content

Does a Caffeine Gum Improve 5 km Run Performance in a Competition/Field Setting?

Does a Commercial Caffeine Supplement Improve 5 km Run Performance in a Field Setting?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02473575
Enrollment
36
Registered
2015-06-16
Start date
2015-06-30
Completion date
2016-01-31
Last updated
2016-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Running Performance

Keywords

Caffeine, running, performance

Brief summary

The purpose of this study is to determine whether caffeine gum improves the performance of runners completing free timed mass participation 5 km runs in the United Kingdom (UK)

Detailed description

The study will investigate the ability of an acute intake of caffeine gum to improve performance in recreationally trained runners completing park runs. Park runs are free, timed 5 km mass participation running events that are held in a number of parks around the UK every Saturday morning. A total of 60 recreationally trained runners will be recruited to the study. Of these, 30 will be assigned to a randomised placebo-controlled double-blind cross-over trial. The remaining 30 will be assigned to a non-intervention comparison group. The non-intervention group will be used to account for the effect of changing environmental conditions on running performance. All participants will complete two 5 km park runs separated by no more than 2 weeks. Participants on the intervention study arms will consume either caffeine or placebo gum 30 minutes before they run. The order of consumption will be randomised. The caffeine gum will contain 300 mg (with an approximate 85% bioavailability). Participants will be asked to abstain from any caffeine containing beverages or food for 18 hours before each run. They will also be asked to record their dietary intake for the day before and the morning of the run and to repeat this for their second trial. Physical activity on the days leading up to each 5 km run will also be recorded and participants will be asked to closely replicate their activity in the week leading up to each trial. They will also be asked to keep training intensity and duration light during the 48 hours leading up to each trial. The primary outcome measure will be change in overall time for the 5 km runs. Other outcome measures will be ratings of perceived exertion, 1 km split times and average heart rate. The study size was calculated using an online software package (http://www.sportsci.org/resource/stats/), adopting a power of 80% and an alpha of 0.05. Using within-person standard deviation from runners completing a local parkrun and an expected effect size of 1.2% (Bridge and Jones (2006) J Sports Sciences. 24(4):433-9) a sample size of 25 runners was calculated for the intervention study.

Interventions

DIETARY_SUPPLEMENTcaffeine gum

Gum is consumed 30 minutes before commencement of run

DIETARY_SUPPLEMENTplacebo gum

Gum is consumed 30 minutes before commencement of run

Sponsors

Sheffield Hallam University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adult runners with evidence of having recently ran 5 km in under 25 minutes

Exclusion criteria

* Current musculoskeletal injury, history of adverse response to caffeine, presence or history of cardiovascular disease, heart rhythm disorders or hypertension.

Design outcomes

Primary

MeasureTime frameDescription
Change in 5 km run timecalculated after 2nd run (runs separated by 7 days)The difference in finishing time on placebo v caffeine; recorded in seconds

Secondary

MeasureTime frameDescription
Change in ratings of perceived exertion (RPE)calculated after 2nd run (runs separated by 7 days)The difference in RPE on placebo v caffeine; using a 6-20 Borg scale

Other

MeasureTime frameDescription
Change in pacingcalculated after 2nd run (runs separated by 7 days); placebo v caffeine1 km split times in sec will be recorded manually and overall pace using GPS (km/h)
Change in average heart ratecalculated after 2nd runRecorded in beats per minute

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026